Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;83(2):237-279.
doi: 10.1016/j.jinf.2021.05.009. Epub 2021 May 13.

Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection

Affiliations
Comment

Clinical efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection

Stephen Winchester et al. J Infect. 2021 Aug.

Abstract

Baek et al.1 investigated the duration of COVID-19 virus shedding in infected patients and demonstrated that even in patients demonstrating prolonged viral clearance, the virus was no longer viable after 15 days post onset of symptoms. Our study aimed to measure whether nitric oxide nasal spray (NONS) further accelerates this reduction in SARS-CoV-2 RNA load versus a control arm with saline spray. Our study recruited 80 participants who were divided into a NONS treatment arm or a placebo arm to test the efficacy of NONS as a treatment for mild COVID-19 infection.

Keywords: Antimicrobial; Antiviral; COVID-19; Coronavirus; Nasal Spray; Nitric oxide; Prevention; SARS-CoV-2; Treatment.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Mean Log(10) SARS-CoV-2 RNA at days 1 to 6 Shown is the difference in the change from baseline in SARS-CoV-2 RNA between the active (NONS) group and the placebo (saline) group from day 1 to day 6. The I bars represent standard error.

Comment on

References

    1. Baek Y.J., Lee Y.J., Yoon J.S. Duration of culturable SARS-CoV-2 within different specimens among mild and severe COVID-19 patients: a longitudinal study. J Infect. 2021 doi: 10.1016/j.jinf.2021.04.025. doi:https://doi.org/ - DOI - PMC - PubMed
    1. Johns Hopkins University and Medicine . Johns Hopkins University; 2021. COVID-19 map - Johns Hopkins Coronavirus Resource Center.https://coronavirus.jhu.edu/map.html Accessed 14 March.
    1. World Health Organization. Coronavirus disease (COVID-19): herd immunity, lockdowns and COVID-19.https://www.who.int/news-room/q-a-detail/herd-immunity-lockdowns-and-cov.... December 31, 2020. Accessed February 27, 2021.
    1. Moncada S., Higgs E. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eu Jof Clin Invest. 1991;21(4):361–374. - PubMed
    1. Fang F. 1997. Perspectives series: host/pathogen interactions. mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 1997;99(12):2818–2825. - PMC - PubMed